Progressive Muscle Relaxation Exercises on Sleep, Fatigue, Pain in Lymphoma Patients
Effects of Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Lymphoma Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
With regular practice, relaxation has been found to have many benefits such as reducing sensitivity to pain and fatigue, facilitating the transition to sleep, and improving quality of life. Therefore, this study was planned to examine the effects of progressive muscle relaxation exercises applied to lymphoma patients on sleep, fatigue, and pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2025
CompletedFirst Submitted
Initial submission to the registry
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 9, 2025
March 1, 2025
1 month
April 2, 2025
April 2, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Visual Analog Scale
The patients were asked to mark their level of pain during relaxation or activities on a 10 cm vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.
Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)
Visual Analog Scale
The patients were asked to mark their level of pain during relaxation or activities on a 10 cm vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.
After the intervention (After progressive muscle relaxation exercises applied in week 6)
The Piper Fatigue Scale
It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items). Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints. Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.
Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)
The Piper Fatigue Scale
It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items). Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints. Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.
After the intervention (After progressive muscle relaxation exercises applied in week 6)
Secondary Outcomes (2)
Pittsburgh Sleep Quality Index (PSQI)
Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)
Pittsburgh Sleep Quality Index (PSQI)
After the intervention (After progressive muscle relaxation exercises applied in week 6)
Study Arms (2)
Progressive muscle relaxation exercises
EXPERIMENTALA total of 18 sessions of progressive relaxation were performed, 3 days a week for 6 weeks.
Control group
NO INTERVENTIONRoutine maintenance will be applied
Interventions
A total of 18 sessions of progressive relaxation were performed, 3 days a week for 6 weeks.
Eligibility Criteria
You may qualify if:
- Being over 18 years of age
- Being able to communicate adequately
- Not having a psychiatric problem
- Those who are determined by a physician to have no physical obstacle to exercise
- Individuals who can use technological devices
- Patients who have had at least 3 cycles
You may not qualify if:
- Those with communication problems
- Those with psychiatric problems
- Patients doing any exercise
- Individuals with phones that do not have a voice recording feature
- Individuals with phones that do not have a WhatsApp feature
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Sabahattin Zaim University, Faculty of Health Sciences,
Küçükçekmece, Istanbul, 34034, Turkey (Türkiye)
Related Publications (2)
Loh EW, Shih HF, Lin CK, Huang TW. Effect of progressive muscle relaxation on postoperative pain, fatigue, and vital signs in patients with head and neck cancers: A randomized controlled trial. Patient Educ Couns. 2022 Jul;105(7):2151-2157. doi: 10.1016/j.pec.2021.10.034. Epub 2021 Nov 3.
PMID: 34785078RESULTTan L, Fang P, Cui J, Yu H, Yu L. Effects of progressive muscle relaxation on health-related outcomes in cancer patients: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2022 Nov;49:101676. doi: 10.1016/j.ctcp.2022.101676. Epub 2022 Oct 31.
PMID: 36332326RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Zülfünaz Özer, PhD
İstanbul Sabahattin Zaim Üniversitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 2, 2025
First Posted
April 9, 2025
Study Start
March 3, 2025
Primary Completion
April 7, 2025
Study Completion
June 30, 2025
Last Updated
April 9, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Nonre